This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Estia Health マネジメント

マネジメント基準チェック /24

Estia Health'sの CEO はSean Biltonで、 Jul2022年に任命され、の在任期間は 1.42年です。の年間総報酬はA$ 1.31Mで、 54.4%給与と45.6%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.43%を直接所有しており、その価値はA$ 3.44M 。経営陣と取締役会の平均在任期間はそれぞれ1.7年と6.4年です。

主要情報

Sean Bilton

最高経営責任者

AU$1.3m

報酬総額

CEO給与比率	54.4%
CEO在任期間	1.4yrs
CEOの所有権	0.4%
経営陣の平均在職期間	1.7yrs
取締役会の平均在任期間	6.4yrs

経営陣の近況

Recent updates

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

Feb 25

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Nov 04

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Apr 13

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Mar 08

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Feb 21

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Jan 24

CEO報酬分析

Estia Health の収益と比較して、Sean Bilton の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jun 30 2023	AU$1m	AU$709k	-AU$34m
Mar 31 2023	n/a	n/a	-AU$52m
Dec 31 2022	n/a	n/a	-AU$70m
Sep 30 2022	n/a	n/a	-AU$61m
Jun 30 2022	AU$905k	AU$496k	-AU$52m
Mar 31 2022	n/a	n/a	-AU$25m
Dec 31 2021	n/a	n/a	AU$3m
Sep 30 2021	n/a	n/a	AU$4m
Jun 30 2021	AU$640k	AU$478k	AU$6m
Mar 31 2021	n/a	n/a	-AU$66m
Dec 31 2020	n/a	n/a	-AU$137m
Sep 30 2020	n/a	n/a	-AU$127m
Jun 30 2020	AU$551k	AU$479k	-AU$117m
Mar 31 2020	n/a	n/a	-AU$41m
Dec 31 2019	n/a	n/a	AU$35m
Sep 30 2019	n/a	n/a	AU$38m
Jun 30 2019	AU$760k	AU$331k	AU$41m

報酬と市場: Seanの総報酬 ($USD 882.91K ) は、 Australian市場 ($USD 826.66K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Seanの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Sean Bilton

1.4yrs

在職期間

AU$1,305,208

報酬

Mr. Sean Bilton serves as Chief Executive Officer, Managing Director and Director of Estia Health Limited since July 11 2022. He was Chief Operating Officer at Estia Health Limited since October 23, 2018 u...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Sean Bilton	CEO, MD & Director	1.4yrs	AU$1.31m	0.43% A$ 3.4m
Damian Hiser	Chief Operating Officer	1.4yrs	AU$800.07k	0.044% A$ 354.6k
Anthony Rice	Chief Financial Officer	less than a year	データなし	データなし
Fiona Caldwell	Chief Information Officer	6.2yrs	データなし	データなし
Suzy Watson	General Counsel & Chief Privacy Officer	9.2yrs	データなし	データなし
Cath Gillard	Chief People Officer	1.6yrs	データなし	データなし
Leanne Laidler	Chief Quality & Risk Officer	4.6yrs	データなし	データなし
Michael Lockwood	Chief Development & Property Officer	1.7yrs	データなし	データなし
Leanne Ralph	Company Secretary	4.7yrs	データなし	データなし

1.7yrs

平均在職期間

経験豊富な経営陣: EHEの経営陣は経験豊富とはみなされません ( 1.7年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Sean Bilton	CEO, MD & Director	1.4yrs	AU$1.31m	0.43% A$ 3.4m
Paul Foster	Independent Non-Executive Director	7.8yrs	AU$145.00k	0.0092% A$ 73.9k
Gary Weiss	Independent Non-Executive Chairman	7.8yrs	AU$280.00k	0.040% A$ 318.2k
Norah Barlow	Independent Non-Executive Director	9.1yrs	AU$125.00k	0.050% A$ 398.7k
Helen Kurincic	Independent Non-Executive Director	6.4yrs	AU$145.00k	0.019% A$ 154.0k
Karen Lee Penrose	Independent Non-Executive Director	5.2yrs	AU$135.00k	0.017% A$ 135.7k
Simon Willcock	Independent Non-executive Director	1.3yrs	AU$100.00k	データなし

6.4yrs

平均在職期間

64.5yo

平均年齢

経験豊富なボード: EHEの取締役会は経験豊富であると考えられます ( 6.4年の平均在任期間)。

This company listing is no longer active

Estia Health マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Independent Non-Executive Chairman recently bought AU$52k worth of stock

CEO, MD & Director recently bought AU$106k worth of stock

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

Consensus EPS estimates fall by 15%

Price target increased by 12% to AU$2.83

Independent Non-Executive Chairman recently bought AU$52k worth of stock

Consensus EPS estimates fall by 22%, revenue upgraded

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought AU$106k worth of stock

Consensus forecasts updated

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Consensus estimates of losses per share improve by 51%

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Consensus forecasts updated

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

Consensus forecasts updated

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings: EPS misses analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Consensus forecasts updated

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Price target increased to AU$2.15

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Price target raised to AU$1.94

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: AU$1.96

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Is Estia Health (ASX:EHE) Using Too Much Debt?

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares?

New 90-day high: AU$1.63

New 90-day low: AU$1.36

New 90-day low: AU$1.37

Non-Executive Director recently bought AU$101k worth of stock

Price target lowered to AU$1.62

Earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Did Estia Health Limited (ASX:EHE) Insiders Buy Up More Shares?

Is There Now An Opportunity In Estia Health Limited (ASX:EHE)?

Estia Health Limited(ASX:EHE) dropped from S&P/ASX 200 Index

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24